Comis Symposium โ€“ Fall 2022


Robert L. Comis, MD Translational Science Symposium
Real World Data (RWD)
October 26, 2022
Washington, DC

This symposium is named for the ECOG-ACRIN Cancer Research Groupโ€™s late Group Co-Chair Robert L. Comis, MD (pictured at left). The potential of translational science to advance cancer diagnosis, prevention, and treatment was a guiding passion for Dr. Comis, and the symposium honors him in this way. Learn more about Dr. Comis here.


AGENDA

WELCOME AND SUMMARY OF SYMPOSIUM

Peter J. Oโ€™Dwyer, MD and Mitchell D. Schnall, MD, PhD
ECOG-ACRIN Group Co-Chairs, University of Pennsylvania

VALUE PROPOSITION

The Value of RWD and Practical Implementation
Donna R. Rivera, PhamD, MS
US Food and Drug Administration

Pharmaceutical Company Perspective on RWD
Martina von Meyenn, PhD
Roche

Data Sources and Applications for Real World Evidence in Oncology
Ronac Mamtani, MD, MSCE
University of Pennsylvania

ROADMAP FOR IMPLEMENTATION

Looking Beyond Clinical Trials to Inform their Design and Interpretation
David E. Gerber, MD
UT Southwestern Medical Center

Real World Data; Reaching Inaccessible Populations and Casting a Broad Net
Otis W. Brawley, MD
Johns Hopkins University

Innovating Evidence Generation - An Industry Perspective
Marlene Thomas, PhD
Roche

Considerations for Use of Real World Data in Extrenal Controls and Novel Trial Designs
Meghna Samant, PhD
Flatiron Health

PANEL DISCUSSION

Peter J. Oโ€™Dwyer, MD and Mitchell D. Schnall, MD, PhD
ECOG-ACRIN, University of Pennsylvania

CLOSING REMARKS

Mitchell D. Schnall, MD, PhD
ECOG-ACRIN, University of Pennsylvania

Download the printed program to read speaker bios.

ย 

ย 

 
ECOG-ACRIN Cancer Research Group